NFE2L2 and diabetes mellitus: We also examined human RPTCs (HK2) with or without NRF2 KO via CRISPR-Cas9 genome editing, cultured in normal-glucose or high-glucose milieu ± FFA added, and the kidneys of humans with or without diabetes.